Dermicea
Turnover is estimated at about €92,000, probably between €66,000 and €130,000. The micro format does not state turnover.
Balance sheet
balance sheet total €132,473 on 31-12-2025in euro
in euro
Position in the sector
4.5%
Higher than 10% of the 21,385 companies filing micro accounts in human health (NACE 86) in 2025.
0.92
Higher than 16% of the 20,936 companies filing micro accounts in human health (NACE 86) in 2025.
8.4%
Higher than 22% of the 21,236 companies filing micro accounts in human health (NACE 86) in 2025.
Net result: bottom quarter · Equity: bottom quarter · Balance sheet total: middle half · Working capital: bottom quarter
Key figures and ratios
per financial year, computed from the annual accounts| Line | Trend | 2025 | 2024 | 2023 | 2022 | 20219 months |
|---|---|---|---|---|---|---|
| 26,460 | 84,986 | 80,171 | 75,572 | 102,326 | ||
| 20,456 | 69,815 | 63,690 | 60,565 | 81,394 | ||
| 0 | 0 | 40,736 | 0 | 6,199 | ||
| -39,847 | 10,673 | -4,667 | 43,275 | - | ||
| -9,128 | 80,603 | 70,554 | 140,760 | 80,195 | ||
| 4.5% | 55.2% | 32.7% | 99.9% | 92.1% | ||
| 0.92 | 2.34 | 1.48 | - | 11.78 | ||
| 21.25 | 0.81 | 2.06 | 0.00 | 0.09 | ||
| 185.9% | 63.7% | 69.6% | 40.7% | 94.2% | ||
| 8.4% | 35.2% | 22.8% | 40.7% | 86.7% | ||
| 26.91 | 62.46 | 77.82 | over 100 | over 100 |
A Belgian filing has no cash-flow statement. Cash flow is therefore an approximation, derived from the income statement. Investment is the acquisitions in the notes and, without them, the balance-sheet move.
Filed annual accounts
as filed with the National Bank, click a year to choose it| Line | Trend | 2025 | 2024 | 2023 | 2022 | 20219 months |
|---|---|---|---|---|---|---|
| Balance sheet: assets | ||||||
20/58 |
132,473 | 171,901 | 258,079 | 145,838 | 93,828 | |
21/28 |
21,969 | 31,357 | 40,744 | 4,952 | 6,192 | |
22/27 |
21,969 | 31,357 | 40,744 | 4,952 | 6,192 | |
24 |
1,233 | 2,473 | 3,713 | 4,952 | 6,192 | |
25 |
20,736 | 28,884 | 37,031 | - | - | |
29/58 |
110,504 | 140,545 | 217,336 | 140,886 | 87,636 | |
40/41 |
13,806 | 4,000 | 91,449 | 9,939 | - | |
40 |
3,806 | - | 4,949 | - | - | |
41 |
10,000 | 4,000 | 86,500 | 9,939 | - | |
54/58 |
96,448 | 136,295 | 125,621 | 130,288 | 87,013 | |
490/1 |
250 | 250 | 266 | 658 | 622 | |
| Balance sheet: equity and liabilities | ||||||
10/49 |
132,473 | 171,901 | 258,079 | 145,838 | 93,828 | |
10/15 |
5,955 | 94,885 | 84,457 | 145,713 | 86,387 | |
10/11 |
5,000 | 5,000 | 5,000 | 5,000 | 5,000 | |
13 |
955 | 89,885 | 79,457 | 140,713 | 81,387 | |
133 |
955 | 89,885 | 79,457 | 140,713 | 81,387 | |
17/49 |
126,518 | 77,016 | 173,622 | 126 | 7,440 | |
17 |
6,887 | 17,074 | 26,840 | - | - | |
170/4 |
6,887 | 17,074 | 26,840 | - | - | |
42/48 |
119,632 | 59,941 | 146,782 | 126 | 7,440 | |
42 |
10,187 | 9,766 | 9,362 | - | - | |
44 |
- | - | - | 126 | 6,527 | |
440/4 |
- | - | - | 126 | 6,527 | |
45 |
- | - | 137,420 | - | 823 | |
450/3 |
- | - | 15,400 | - | 823 | |
454/9 |
- | - | 122,020 | - | - | |
47/48 |
109,444 | 50,176 | - | - | 91 | |
| Income statement | ||||||
9900 |
29,747 | 88,129 | 81,493 | 75,674 | 102,708 | |
630 |
9,387 | 9,387 | 4,945 | 1,240 | 7 | |
640/8 |
3,287 | 3,143 | 1,322 | 102 | 383 | |
9901 |
17,073 | 75,599 | 75,226 | 74,332 | 102,319 | |
75/76B |
0 | 2,168 | - | 184 | - | |
75 |
0 | 2,168 | - | 184 | - | |
65/66B |
983 | 1,361 | 1,030 | 191 | 109 | |
65 |
983 | 1,361 | 1,030 | 191 | 109 | |
9903 |
16,089 | 76,407 | 74,196 | 74,325 | 102,210 | |
67/77 |
5,020 | 15,978 | 15,451 | 15,000 | 20,823 | |
9904 |
11,069 | 60,428 | 58,745 | 59,325 | 81,387 | |
9905 |
11,069 | 60,428 | 58,745 | 59,325 | 81,387 | |
| Appropriation of the result | ||||||
9906 |
11,069 | 60,428 | 58,745 | 59,325 | 81,387 | |
791/2 |
88,931 | - | 120,000 | - | - | |
691/2 |
- | 10,428 | 58,745 | 59,325 | 81,387 | |
6921 |
- | 10,428 | 58,745 | 59,325 | 81,387 | |
694/7 |
100,000 | 50,000 | 120,000 | - | - | |
694 |
100,000 | 50,000 | 120,000 | - | - | |
| Document | ||||||
The full notes are in the accounts filed with the NBB.
Source: Annual accounts 2025 at the NBB, filed on 30-06-2026.
Filings
each dot is a set of accounts, on the day it reached the National Bank| Financial year | Type | Filed | Reference | Document |
|---|---|---|---|---|
| 31-12-2025 | micro format | 30-06-2026 | 2026-00223029 | |
| 31-12-2024 | micro format | 30-08-2025 | 2025-00447660 | |
| 31-12-2023 | micro format | 30-08-2024 | 2024-00411712 | |
| 31-12-2022 | micro format | 31-08-2023 | 2023-00393939 | |
| 31-12-2021 | micro format | 16-06-2022 | 2022-20067007 |
Investments
fixed assets acquired| Item | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Tangible fixed assets | - | - | €40,736 | - | €6,199 |
| €9,387 | €9,387 | €4,945 | €1,240 | €7 |
Source: notes to the 2021 to 2025 annual accounts (statement of fixed assets)
Insights on Dermicea
The operating result for 2025 is 77% lower than in 2024 and the lowest since 2022.
Debt's share of the balance-sheet total rises from 44.8% to 95.5%. Equity is lower and debt is higher.